ArticleBMC medicine2026

Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study.

Zihao Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.